 | | Elvitegravir |  | | Published
October 15, 2012 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-02 | | | Selected Reference | | 4. | Molina JM, LaMarca A, Andrade-Villanueva J, et al; Study 145 Team. Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study. Lancet Infect Dis. 2012 Jan;12(1):27-35. | |
|
|
|
